SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000891293-22-000017
Filing Date
2022-04-19
Accepted
2022-04-19 17:22:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ctic_2022defa14a.htm DEFA14A 8091
2 image_0a.jpg GRAPHIC 143100
3 image_1a.jpg GRAPHIC 79222
  Complete submission text file 0000891293-22-000017.txt   315446
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-28386 | Film No.: 22835682
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences